Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.

Shahar ShellyChristopher KleinP James B Dyck Pritikanta PaulMichelle L MauermannSarah E BeriniBenjamin HoweJames P FryerEati BasalMohammad Bakri Hammami Ruple S LaughlinAndrew McKeonSean J PittockJohn MillsDivyanshu Dubey

Published in: Neurology (2021)

This study provides Class III evidence that NF155-IgG4 seropositive patients, compared to typical CIDP patients, present with distal more than proximal muscle weakness, positive sensory symptoms, and gait ataxia.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
skeletal muscle
immune response
adipose tissue
signaling pathway
insulin resistance
early onset
metabolic syndrome
patient reported outcomes
cell proliferation
patient reported
depressive symptoms
lps induced